FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

33622711000001108: Cabozantinib 20mg tablets 30 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Dec 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
101444101000001119 Cabozantinib 20mg tablets 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
101444201000001114 Cabozantinib 20mg tablets 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


2 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cabozantinib 20mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cabozantinib 20mg tablets 30 tablet Has specific active ingredient Cabozantinib s-malate true Inferred relationship Existential restriction modifier
Cabozantinib 20mg tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Cabozantinib 20mg tablets 30 tablet Has VMP Cabozantinib 20mg tablets true Inferred relationship Existential restriction modifier
Cabozantinib 20mg tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cabozantinib 20mg tablets 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cabozantinib 20mg tablets 30 tablet Has specific active ingredient Cabozantinib s-malate false Inferred relationship Existential restriction modifier
Cabozantinib 20mg tablets 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cabozantinib 20mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance cabozantinib false Inferred relationship Existential restriction modifier
Cabozantinib 20mg tablets 30 tablet Has basis of strength substance cabozantinib false Inferred relationship Existential restriction modifier
Cabozantinib 20mg tablets 30 tablet Has basis of strength substance Cabozantinib true Inferred relationship Existential restriction modifier
Cabozantinib 20mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cabozantinib false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Cabometyx 20mg tablets (Originalis B.V.) 30 tablet Is a True Cabozantinib 20mg tablets 30 tablet Inferred relationship Existential restriction modifier
Cabometyx 20mg tablets (Ipsen Ltd) 30 tablet Is a True Cabozantinib 20mg tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start